Invention Grant
- Patent Title: Method and kit for determining the probability that a patient will develop a severe case of dengue
-
Application No.: US15912730Application Date: 2018-03-06
-
Publication No.: US10309965B2Publication Date: 2019-06-04
- Inventor: Frédéric Bedin , Romain Fragnoud
- Applicant: BIOMERIEUX
- Applicant Address: FR Marcy L'Etoile
- Assignee: BIOMERIEUX
- Current Assignee: BIOMERIEUX
- Current Assignee Address: FR Marcy L'Etoile
- Agency: Oliff PLC
- Priority: FR1451274 20140218
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C07K16/18 ; C07K16/28 ; C07K16/44 ; G01N33/569
Abstract:
A kit for determining whether a patient will develop severe dengue includes a binding partner for platelet factor 4 and a binding partner for at least one member selected from the group consisting of dengue virus NS1 protein, olfactomedin 4, and α2-macroglobulin. The kit may further include a label reagent capable of generating a detectable signal.
Public/Granted literature
- US20180196046A1 METHOD AND KIT FOR DETERMINING THE PROBABILITY THAT A PATIENT WILL DEVELOP A SEVERE CASE OF DENGUE Public/Granted day:2018-07-12
Information query
